Skip to main content
Erschienen in: Drugs & Aging 12/2019

05.11.2019 | Original Research Article

Assessing the Importance of Factors Associated with Cost-Related Nonadherence to Medication for Older US Medicare Beneficiaries

verfasst von: Dian Gu, Chan Shen

Erschienen in: Drugs & Aging | Ausgabe 12/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Prescription drug costs have been rising rapidly in the USA, contributing to the persistent problem of cost-related medication nonadherence (CRN) among older Medicare beneficiaries. Given the importance of CRN and the negative outcomes associated with it, it is important to examine the factors that affect CRN. This study aims to estimate the factors influencing CRN among older Medicare beneficiaries and to rank their relative contribution in explaining CRN.

Methods

We used a 2015 Medicare Current Beneficiary Survey linked to Medicare claims data to identify older Medicare beneficiaries aged 65 years and over. Multivariate logistic regression was performed to identify factors associated with CRN. Factors included in the regression analyses were based on a conceptual framework adapted from Piette et al., including main effects (financial factors and regimen complexity) and contextual factors (sociodemographic, lifestyle and health factors). Dominance analysis was conducted to determine their relative importance in predicting CRN.

Results

Our study sample included 4427 older Medicare beneficiaries, 13.43% of whom reported CRN. For main effects, drug coverage and regimen complexity were significantly associated with CRN. Compared to beneficiaries with public coverage, those with private drug coverage were less likely to report CRN while those without drug coverage were more likely to report CRN. Having more than two monthly prescriptions was also associated with higher CRN. Significant contextual factors included age, activities of daily living limitations, perceived health status, cancer, rheumatoid arthritis, non-rheumatoid arthritis, depression, and lung disease. Dominance analysis showed drug coverage was the most influential factor in explaining CRN, after which age, ADL limitations, and depression ranked in sequence.

Conclusions

These findings can help policy makers understand the relative importance of factors affecting CRN and identify the most important areas for intervention to improve CRN.
Literatur
1.
Zurück zum Zitat He W, Goodkind D, Kowal PR. An aging world: 2015. Washington, DC: United States Census Bureau; 2016. He W, Goodkind D, Kowal PR. An aging world: 2015. Washington, DC: United States Census Bureau; 2016.
2.
Zurück zum Zitat Nobili A, Garattini S, Mannucci PM. Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium. J Comorbidities. 2011;1:28–44. Nobili A, Garattini S, Mannucci PM. Multiple diseases and polypharmacy in the elderly: challenges for the internist of the third millennium. J Comorbidities. 2011;1:28–44.
3.
Zurück zum Zitat Schumock GT, Stubbings J, Wiest MD, Li EC, Suda KJ, Matusiak LM, et al. National trends in prescription drug expenditures and projections for 2018. Am J Health Syst Pharm. 2018;75:1023–38.PubMed Schumock GT, Stubbings J, Wiest MD, Li EC, Suda KJ, Matusiak LM, et al. National trends in prescription drug expenditures and projections for 2018. Am J Health Syst Pharm. 2018;75:1023–38.PubMed
4.
Zurück zum Zitat Kesselheim AS, Avorn J, Sarpatwari A. The high cost of prescription drugs in the United States: origins and prospects for reform. JAMA. 2016;316:858–71.PubMed Kesselheim AS, Avorn J, Sarpatwari A. The high cost of prescription drugs in the United States: origins and prospects for reform. JAMA. 2016;316:858–71.PubMed
5.
Zurück zum Zitat Madden JM, Graves AJ, Zhang F, Adams AS, Briesacher BA, Ross-Degnan D, et al. Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA. 2008;299:1922–8.PubMedPubMedCentral Madden JM, Graves AJ, Zhang F, Adams AS, Briesacher BA, Ross-Degnan D, et al. Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA. 2008;299:1922–8.PubMedPubMedCentral
6.
Zurück zum Zitat Piette JD, Heisler M, Wagner TH. Cost-related medication underuse among chronically III adults: the treatments people forgo, how often, and who is at risk. Am J Public Health. 2004;94:1782–7.PubMedPubMedCentral Piette JD, Heisler M, Wagner TH. Cost-related medication underuse among chronically III adults: the treatments people forgo, how often, and who is at risk. Am J Public Health. 2004;94:1782–7.PubMedPubMedCentral
7.
Zurück zum Zitat Tamblyn R, Laprise R, Hanley JA, Abrahamowicz M, Scott S, Mayo N, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA. 2001;285:421–9.PubMed Tamblyn R, Laprise R, Hanley JA, Abrahamowicz M, Scott S, Mayo N, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA. 2001;285:421–9.PubMed
8.
Zurück zum Zitat Heisler M, Langa KM, Eby EL, Fendrick AM, Kabeto MU, Piette JD. The health effects of restricting prescription medication use because of cost. Med Care. 2004;42:626–34.PubMed Heisler M, Langa KM, Eby EL, Fendrick AM, Kabeto MU, Piette JD. The health effects of restricting prescription medication use because of cost. Med Care. 2004;42:626–34.PubMed
9.
Zurück zum Zitat Zivin K, Ratliff S, Heisler MM, Langa KM, Piette JD. Factors influencing cost-related nonadherence to medication in older adults: a conceptually based approach. Value Health. 2010;13:338–45.PubMedPubMedCentral Zivin K, Ratliff S, Heisler MM, Langa KM, Piette JD. Factors influencing cost-related nonadherence to medication in older adults: a conceptually based approach. Value Health. 2010;13:338–45.PubMedPubMedCentral
10.
Zurück zum Zitat Piette JD, Heisler M, Horne R, Alexander GC. A conceptually based approach to understanding chronically ill patients’ responses to medication cost pressures. Soc Sci Med. 2006;62:846–57.PubMed Piette JD, Heisler M, Horne R, Alexander GC. A conceptually based approach to understanding chronically ill patients’ responses to medication cost pressures. Soc Sci Med. 2006;62:846–57.PubMed
11.
Zurück zum Zitat Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med. 2007;22:864–71.PubMedPubMedCentral Briesacher BA, Gurwitz JH, Soumerai SB. Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med. 2007;22:864–71.PubMedPubMedCentral
12.
Zurück zum Zitat Zhang JX, Lee JU, Meltzer DO. Risk factors for cost-related medication non-adherence among older patients with diabetes. World J Diabetes. 2014;5:945–50.PubMedPubMedCentral Zhang JX, Lee JU, Meltzer DO. Risk factors for cost-related medication non-adherence among older patients with diabetes. World J Diabetes. 2014;5:945–50.PubMedPubMedCentral
13.
Zurück zum Zitat Zhang JX, Meltzer DO. Risk factors for cost-related medication non-adherence among older patients with cancer. Integr Cancer Sci Ther. 2015;2:300–4.PubMedPubMedCentral Zhang JX, Meltzer DO. Risk factors for cost-related medication non-adherence among older patients with cancer. Integr Cancer Sci Ther. 2015;2:300–4.PubMedPubMedCentral
14.
Zurück zum Zitat Blumberg DM, Prager AJ, Liebmann JM, Cioffi GA, De Moraes CG. Cost-related medication nonadherence and cost-saving behaviors among patients with glaucoma before and after the implementation of Medicare Part D. JAMA Ophthalmol. 2015;133:985–96.PubMed Blumberg DM, Prager AJ, Liebmann JM, Cioffi GA, De Moraes CG. Cost-related medication nonadherence and cost-saving behaviors among patients with glaucoma before and after the implementation of Medicare Part D. JAMA Ophthalmol. 2015;133:985–96.PubMed
15.
Zurück zum Zitat Harrold LR, Briesacher BA, Peterson D, Beard A, Madden J, Zhang F, et al. Cost-related medication nonadherence in older patients with rheumatoid arthritis. J Rheumatol. 2013;40:137–43.PubMed Harrold LR, Briesacher BA, Peterson D, Beard A, Madden J, Zhang F, et al. Cost-related medication nonadherence in older patients with rheumatoid arthritis. J Rheumatol. 2013;40:137–43.PubMed
16.
Zurück zum Zitat Kang H, Lobo JM, Kim S, Sohn M-W. Cost-related medication non-adherence among US adults with diabetes. Diabetes Res Clin Pract. 2018;143:24–33.PubMedPubMedCentral Kang H, Lobo JM, Kim S, Sohn M-W. Cost-related medication non-adherence among US adults with diabetes. Diabetes Res Clin Pract. 2018;143:24–33.PubMedPubMedCentral
17.
Zurück zum Zitat Gonzalez JS, Peyrot M, McCarl LA, Collins EM, Serpa L, Mimiaga MJ, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008;31:2398–403.PubMedPubMedCentral Gonzalez JS, Peyrot M, McCarl LA, Collins EM, Serpa L, Mimiaga MJ, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008;31:2398–403.PubMedPubMedCentral
19.
Zurück zum Zitat Burcu M, Alexander GC, Ng X, Harrington D. Construct validity and factor structure of survey-based assessment of cost-related medication burden. Med Care. 2015;53:199–206.PubMed Burcu M, Alexander GC, Ng X, Harrington D. Construct validity and factor structure of survey-based assessment of cost-related medication burden. Med Care. 2015;53:199–206.PubMed
20.
Zurück zum Zitat Piette JD, Beard A, Rosland AM, McHorney CA. Beliefs that influence cost-related medication non-adherence among the “haves” and “have nots” with chronic diseases. Patient Pref Adherence. 2011;5:389–96. Piette JD, Beard A, Rosland AM, McHorney CA. Beliefs that influence cost-related medication non-adherence among the “haves” and “have nots” with chronic diseases. Patient Pref Adherence. 2011;5:389–96.
22.
Zurück zum Zitat Bambauer KZ, Safran DG, Ross-Degnan D, Zhang F, Adams AS, Gurwitz J, et al. Depression and cost-related medication nonadherence in Medicare beneficiaries. Arch Gen Psychiatry. 2007;64:602–8.PubMed Bambauer KZ, Safran DG, Ross-Degnan D, Zhang F, Adams AS, Gurwitz J, et al. Depression and cost-related medication nonadherence in Medicare beneficiaries. Arch Gen Psychiatry. 2007;64:602–8.PubMed
23.
Zurück zum Zitat Zivin K, Madden JM, Zhang F, Soumerai SB, Graves AJ. Cost-related medication nonadherence among beneficiaries with depression following Medicare Part D. Am J Geriatr Psychiatry. 2009;17:1068–76.PubMedPubMedCentral Zivin K, Madden JM, Zhang F, Soumerai SB, Graves AJ. Cost-related medication nonadherence among beneficiaries with depression following Medicare Part D. Am J Geriatr Psychiatry. 2009;17:1068–76.PubMedPubMedCentral
24.
Zurück zum Zitat Rogers WH, Wilson IB, Bungay KM, Cynn DJ, Adler DA. Assessing the performance of a new depression screener for primary care (PC-SAD). J Clin Epidemiol. 2002;55:164–75.PubMed Rogers WH, Wilson IB, Bungay KM, Cynn DJ, Adler DA. Assessing the performance of a new depression screener for primary care (PC-SAD). J Clin Epidemiol. 2002;55:164–75.PubMed
25.
Zurück zum Zitat Rogers WH, Adler DA, Bungay KM, Wilson IB. Depression screening instruments made good severity measures in a cross-sectional analysis. J Clin Epidemiol. 2005;58:370–7.PubMed Rogers WH, Adler DA, Bungay KM, Wilson IB. Depression screening instruments made good severity measures in a cross-sectional analysis. J Clin Epidemiol. 2005;58:370–7.PubMed
26.
Zurück zum Zitat Azen R, Budescu DV. The dominance analysis approach for comparing predictors in multiple regression. Psychol Methods. 2003;8:129–48.PubMed Azen R, Budescu DV. The dominance analysis approach for comparing predictors in multiple regression. Psychol Methods. 2003;8:129–48.PubMed
27.
Zurück zum Zitat Azen R, Traxel N. Using dominance analysis to determine predictor importance in logistic regression. J Educ Behav Stat. 2009;34:319–47. Azen R, Traxel N. Using dominance analysis to determine predictor importance in logistic regression. J Educ Behav Stat. 2009;34:319–47.
28.
Zurück zum Zitat Grömping U. Estimators of relative importance in linear regression based on variance decomposition. Am Statistician. 2007;261:139–47. Grömping U. Estimators of relative importance in linear regression based on variance decomposition. Am Statistician. 2007;261:139–47.
29.
Zurück zum Zitat Luchman JN. Determining subgroup difference importance with complex survey designs: an application of weighted dominance analysis. Surv Pract. 2015;8:1–10. Luchman JN. Determining subgroup difference importance with complex survey designs: an application of weighted dominance analysis. Surv Pract. 2015;8:1–10.
30.
Zurück zum Zitat Soumerai SB, Pierre-Jacques M, Zhang F, Ross-Degnan D, Adams AS, Gurwitz J, et al. Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit. Arch Intern Med. 2006;166:1829–35.PubMed Soumerai SB, Pierre-Jacques M, Zhang F, Ross-Degnan D, Adams AS, Gurwitz J, et al. Cost-related medication nonadherence among elderly and disabled medicare beneficiaries: a national survey 1 year before the medicare drug benefit. Arch Intern Med. 2006;166:1829–35.PubMed
32.
Zurück zum Zitat Gellad WF, Grenard J, McGlynn EA, Gellad WF, Grenard JL, McGlynn EA. A review of barriers to medication adherence. In: A framework for driving policy options. Santa Monica, CA: RAND Corp; 2009. Gellad WF, Grenard J, McGlynn EA, Gellad WF, Grenard JL, McGlynn EA. A review of barriers to medication adherence. In: A framework for driving policy options. Santa Monica, CA: RAND Corp; 2009.
33.
Zurück zum Zitat Aziz H, Hatah E, Bakry MM, et al. How payment scheme affects patients’ adherence to medications? A systematic review. Patient Prefer Adherence. 2016;10:837–50.PubMedPubMedCentral Aziz H, Hatah E, Bakry MM, et al. How payment scheme affects patients’ adherence to medications? A systematic review. Patient Prefer Adherence. 2016;10:837–50.PubMedPubMedCentral
34.
Zurück zum Zitat Cohen MJ, Shaykevich S, Cawthon C, Kripalani S, Paasche-Orlow MK, Schnipper JL. Predictors of medication adherence postdischarge: the impact of patient age, insurance status, and prior adherence. J Hosp Med. 2012;7:470–5.PubMedPubMedCentral Cohen MJ, Shaykevich S, Cawthon C, Kripalani S, Paasche-Orlow MK, Schnipper JL. Predictors of medication adherence postdischarge: the impact of patient age, insurance status, and prior adherence. J Hosp Med. 2012;7:470–5.PubMedPubMedCentral
35.
Zurück zum Zitat Gazmararian J, Jacobson KL, Pan Y, Schmotzer B, Kripalani S. Effect of a pharmacy-based health literacy intervention and patient characteristics on medication refill adherence in an urban health system. Ann Pharmacother. 2010;44:80–7.PubMed Gazmararian J, Jacobson KL, Pan Y, Schmotzer B, Kripalani S. Effect of a pharmacy-based health literacy intervention and patient characteristics on medication refill adherence in an urban health system. Ann Pharmacother. 2010;44:80–7.PubMed
36.
Zurück zum Zitat Hinkin CH, Hardy DJ, Mason KI, Castellon SA, Durvasula RS, Lam MN, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004;18(Suppl. 1):S19–25.PubMedPubMedCentral Hinkin CH, Hardy DJ, Mason KI, Castellon SA, Durvasula RS, Lam MN, et al. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004;18(Suppl. 1):S19–25.PubMedPubMedCentral
37.
Zurück zum Zitat Zhang JX, Lee JU, Pandey K, Meltzer DO. Variation in cost-related medication non-adherence with functional limitations and frequency of hospitalization in older adults. Ann Gerontol Geriatric Res. 2015;2(1):1023. Zhang JX, Lee JU, Pandey K, Meltzer DO. Variation in cost-related medication non-adherence with functional limitations and frequency of hospitalization in older adults. Ann Gerontol Geriatric Res. 2015;2(1):1023.
38.
Zurück zum Zitat Chan L, Beaver S, MacLehose RF, Jha A, Maciejewski M, Doctor JN. Disability and health care costs in the Medicare population. Arch Phys Med Rehab. 2002;83:1196–201. Chan L, Beaver S, MacLehose RF, Jha A, Maciejewski M, Doctor JN. Disability and health care costs in the Medicare population. Arch Phys Med Rehab. 2002;83:1196–201.
39.
Zurück zum Zitat MacLachlan M, Mannan H, McAuliffe E. Access to health care of persons with disabilities as an indicator of equity in health systems. Open Med. 2011;5:e10.PubMedPubMedCentral MacLachlan M, Mannan H, McAuliffe E. Access to health care of persons with disabilities as an indicator of equity in health systems. Open Med. 2011;5:e10.PubMedPubMedCentral
40.
Zurück zum Zitat Pellegrino LD, Peters ME, Lyketsos CG, Marano CM. Depression in cognitive impairment. Curr Psychiatry Rep. 2013;15:384.PubMedPubMedCentral Pellegrino LD, Peters ME, Lyketsos CG, Marano CM. Depression in cognitive impairment. Curr Psychiatry Rep. 2013;15:384.PubMedPubMedCentral
41.
Zurück zum Zitat Campbell NL, Boustani MA, Skopelja EN, Gao S, Unverzagt FW, Murray MD. Medication adherence in older adults with cognitive impairment: a systematic evidence-based review. Am J Geriatr Pharmacother. 2012;10:165–77.PubMed Campbell NL, Boustani MA, Skopelja EN, Gao S, Unverzagt FW, Murray MD. Medication adherence in older adults with cognitive impairment: a systematic evidence-based review. Am J Geriatr Pharmacother. 2012;10:165–77.PubMed
42.
Zurück zum Zitat Nekhlyudov L, Madden J, Graves AJ, Zhang F, Soumerai SB, Ross-Degnan D. Cost-related medication nonadherence and cost-saving strategies used by elderly Medicare cancer survivors. J Cancer Surviv. 2011;5:395–404.PubMedPubMedCentral Nekhlyudov L, Madden J, Graves AJ, Zhang F, Soumerai SB, Ross-Degnan D. Cost-related medication nonadherence and cost-saving strategies used by elderly Medicare cancer survivors. J Cancer Surviv. 2011;5:395–404.PubMedPubMedCentral
43.
Zurück zum Zitat Tran G, Zafar SY. Financial toxicity and implications for cancer care in the era of molecular and immune therapies. Ann Transl Med. 2018;6(9):166.PubMedPubMedCentral Tran G, Zafar SY. Financial toxicity and implications for cancer care in the era of molecular and immune therapies. Ann Transl Med. 2018;6(9):166.PubMedPubMedCentral
44.
Zurück zum Zitat Peppercorn J. Financial toxicity and societal costs of cancer care: distinct problems require distinct solutions. Oncologist. 2017;22(2):123–5.PubMedPubMedCentral Peppercorn J. Financial toxicity and societal costs of cancer care: distinct problems require distinct solutions. Oncologist. 2017;22(2):123–5.PubMedPubMedCentral
45.
Zurück zum Zitat Aikens JE, Piette JD. Diabetic patients’ medication underuse, illness outcomes, and beliefs about antihyperglycemic and antihypertensive treatments. Diabetes Care. 2009;32:19–24.PubMedPubMedCentral Aikens JE, Piette JD. Diabetic patients’ medication underuse, illness outcomes, and beliefs about antihyperglycemic and antihypertensive treatments. Diabetes Care. 2009;32:19–24.PubMedPubMedCentral
46.
Zurück zum Zitat Piette JD, Heisler M, Wagner TH. Medication characteristics beyond cost alone influence decisions to underuse pharmacotherapy in response to financial pressures. J Clin Epidemiol. 2006;59:739–46.PubMed Piette JD, Heisler M, Wagner TH. Medication characteristics beyond cost alone influence decisions to underuse pharmacotherapy in response to financial pressures. J Clin Epidemiol. 2006;59:739–46.PubMed
47.
Zurück zum Zitat Yap AF, Thirumoorthy T, Kwan YH. Medication adherence in the elderly. J Clin Gerontol Geriatr. 2016;7:64–7. Yap AF, Thirumoorthy T, Kwan YH. Medication adherence in the elderly. J Clin Gerontol Geriatr. 2016;7:64–7.
48.
Zurück zum Zitat Chang-Quan H, Bi-Rong D, Zhen-Chan L, Yuan Z, Yu-Sheng P, Qing-Xiu L. Collaborative care interventions for depression in the elderly: a systematic review of randomized controlled trials. J Investig Med. 2009;57:446–55.PubMed Chang-Quan H, Bi-Rong D, Zhen-Chan L, Yuan Z, Yu-Sheng P, Qing-Xiu L. Collaborative care interventions for depression in the elderly: a systematic review of randomized controlled trials. J Investig Med. 2009;57:446–55.PubMed
Metadaten
Titel
Assessing the Importance of Factors Associated with Cost-Related Nonadherence to Medication for Older US Medicare Beneficiaries
verfasst von
Dian Gu
Chan Shen
Publikationsdatum
05.11.2019
Verlag
Springer International Publishing
Erschienen in
Drugs & Aging / Ausgabe 12/2019
Print ISSN: 1170-229X
Elektronische ISSN: 1179-1969
DOI
https://doi.org/10.1007/s40266-019-00715-3

Weitere Artikel der Ausgabe 12/2019

Drugs & Aging 12/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.